31 Aug 2026
ASTRAZENECA NEW PARTNER TO WIN WIN AWARD
WIN WIN Award welcomes AstraZeneca as a new funding partner, together recognising and rewarding outstanding contributions to a more sustainable future.
The global biopharmaceutical company brings both scale and a strong sustainability track record to the partnership, strengthening WIN WIN Award's work of recognising and rewarding the leaders and solutions driving the world towards a more sustainable future.
AstraZeneca is a global biopharmaceutical company with 96,100 employees across 125 countries. They're tackling sustainability on multiple fronts, from cutting emissions (Scopes 1 and 2 GHG emissions down 88% since 2015) to closing healthcare gaps and improving health equity worldwide.
"Sustainability is a cornerstone of AstraZeneca's operations. No one can solve these challenges alone. Collaboration is the key to success, and we're pleased to join forces with the WIN WIN Award and support their work in recognising the positive forces driving real change towards a more sustainable world," says Karl-Johan Karlsson, Corporate Affairs Director Sweden at AstraZeneca.
WIN WIN Award is a non-profit association funded through partnerships with the public sector, academia and business. As a partner, organisations help bring visibility to the actors and solutions at the forefront of the sustainability transition.
Through knowledge exchange and networking around the prize, partners gain the opportunity to engage and develop their employees, while also creating an arena where the three sectors can collaborate and learn from one another, a collaboration that becomes ever more important as the pace of transition needs to accelerate.
Read more about AstraZeneca's approach to sustainability here.